Correlation Between Hypera SA and Sumitomo Dainippon
Can any of the company-specific risk be diversified away by investing in both Hypera SA and Sumitomo Dainippon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hypera SA and Sumitomo Dainippon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hypera SA and Sumitomo Dainippon Pharma, you can compare the effects of market volatilities on Hypera SA and Sumitomo Dainippon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hypera SA with a short position of Sumitomo Dainippon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hypera SA and Sumitomo Dainippon.
Diversification Opportunities for Hypera SA and Sumitomo Dainippon
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hypera and Sumitomo is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Hypera SA and Sumitomo Dainippon Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sumitomo Dainippon Pharma and Hypera SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hypera SA are associated (or correlated) with Sumitomo Dainippon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sumitomo Dainippon Pharma has no effect on the direction of Hypera SA i.e., Hypera SA and Sumitomo Dainippon go up and down completely randomly.
Pair Corralation between Hypera SA and Sumitomo Dainippon
If you would invest 437.00 in Sumitomo Dainippon Pharma on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Sumitomo Dainippon Pharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 4.35% |
| Values | Daily Returns |
Hypera SA vs. Sumitomo Dainippon Pharma
Performance |
| Timeline |
| Hypera SA |
| Sumitomo Dainippon Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Hypera SA and Sumitomo Dainippon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hypera SA and Sumitomo Dainippon
The main advantage of trading using opposite Hypera SA and Sumitomo Dainippon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hypera SA position performs unexpectedly, Sumitomo Dainippon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sumitomo Dainippon will offset losses from the drop in Sumitomo Dainippon's long position.| Hypera SA vs. Green Cures Botanical | Hypera SA vs. Cann American Corp | Hypera SA vs. Rimrock Gold Corp | Hypera SA vs. Galexxy Holdings |
| Sumitomo Dainippon vs. Hypera SA | Sumitomo Dainippon vs. YourWay Cannabis Brands | Sumitomo Dainippon vs. Cumberland Pharmaceuticals | Sumitomo Dainippon vs. Genomma Lab Internacional |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |